PRELUDE THERAPEUTICS INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $148.00K, a 79.18% decline year-over-year.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $59.00K, a 86.02% decline year-over-year.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $153.00K, a 60.36% decline year-over-year.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $711.00K, a 993.85% increase year-over-year.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2021 was $3.50M, a 3404.00% increase from fiscal 2020.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2020 was $100.00K, a 1900.00% increase from fiscal 2019.
- PRELUDE THERAPEUTICS INC stock issued during period, value, stock options exercised for fiscal 2019 was $5.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-09-30 | $148.00K 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $59.00K 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $153.00K 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $3.50M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $711.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $422.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $386.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $100.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $65.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $31.00K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $5.00K 10-K · filed 2021-03-16 | |
| 2019-06-30 | $5.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |